Sign in
4

Changes in Ownership

PROTHENA CORP PUBLIC LTD CO Filed Acc 0001567619-22-018292

Chief Medical Officer sold 4,000 shares at $60.90 ($243,600)

  • Chief Medical Officer acquired 4,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Garren Hideki Chief Medical Officer 2022-10-03 Option exercise +4,000 $24.90 $99,600 4,000 D: show line 1 in the form
Garren Hideki Chief Medical Officer 2022-10-03 Sale −4,000 $60.90 $243,600 0 D: show line 2 in the form
Open-market sales · 4,000 sh · avg $60.90 · $243,600

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Garren Hideki Chief Medical Officer 2022-10-03 Option exercise · Stock Option (Right to Buy) −4,000 230,000 D: show line 3 in the form
Loading xslF345X03/doc1.xml…